| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.006 |